छोड़कर सामग्री पर जाएँ

Neutral Aurobindo Pharma; target of Rs 600: Motilal Oswal

Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 600 in its research report dated May 29, 2023.

Read More

​ Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 600 in its research report dated May 29, 2023. Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 600 in its research report dated May 29, 2023.  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी